Hodgkin lymphoma: open trials in Belgium

8 open trials have a site in Belgium. Registry data; only the trial team decides who can take part.

NCT06788509
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
Trial Treatment · Phase 1 · Janssen Research & Development, LLC
Universitair Ziekenhuis Gent, Gent
Registry updated 2026-11-04
NCT04970901
A Phase 1b Open-Label Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination with Other Anti-cancer Agents in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (LOTIS-7)
Trial Treatment · Phase 1 · ADC Therapeutics SA
Universitair Ziekenhuis Gent, Gent · Centre Hospitalier Universitaire Dinant Godinne Sainte-Elisabeth-UCL-Namur, Yvoir
Registry updated 2026-09-15
2023-510173-34-00
A long-term follow-up study for patients treated with Galapagos CAR T cell therapies
Trial Treatment · Phase 3 · Lakefront Biotherapeutics
Antwerp University Hospital, Edegem · UZ Leuven, Leuven · Centre Hospitalier Universitaire de Liège, Liège · Algemeen Ziekenhuis Delta, Roeselare · Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe
Registry updated 2026-09-11
NCT04685616
Brentuximab Vedotin in Early Stage Hodgkin Lymphoma
Trial Treatment · Phase 3 · University College, London
Ziekenhuis Aan De Stroom, Antwerp · Antwerp University Hospital, Edegem · UZ Leuven, Leuven · Centre Hospitalier Universitaire Dinant Godinne Sainte-Elisabeth-UCL-Namur, Namur · AZ Delta, Roeselare
Registry updated 2026-07-08
NCT06230224
A trial to learn how effective and safe odronextamab is compared to standard of care for adult participants with previously treated aggressive B-cell Non-Hodgkin Lymphoma.
Trial Treatment · Phase 3 · Regeneron Pharmaceuticals Inc.
Het Ziekenhuisnetwerk Antwerpen, Antwerp · Institut Jules Bordet, Brussels · Universitair Ziekenhuis Gent, Gent · Chu Ucl Namur, Yvoir
Registry updated 2026-05-25
NCT05991388
A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma
Trial Treatment · Phase 2/3 · University of Birmingham
Katholieke Universiteit te Leuven, Leuven
Registry updated 2026-02-20
NCT03852407
Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning
Trial Treatment · Phase 2 · University of Liege
Institut Jules Bordet, Anderlecht · Ziekenhuis Aan De Stroom, Antwerp · Az St-Jan Brugge-Oostende A.V., Brugge · Universiteit Gent, Gent · Vrije Universiteit Brussel, Jette · UZ Leuven, Leuven · Algemeen Ziekenhuis Delta, Roeselare · Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe · Centre Hospitalier Universitaire Dinant Godinne Sainte-Elisabeth-UCL-Namur, Yvoir
Registry updated 2022-10-12
NCT03356054
Phase I-II Study in CD30 Positive Diffuse Large B-cell Lymphoma Patients Refractory to First Line Chemotherapy or in First Relapse
Trial Treatment · Phase 1/2 · Stichting Hemato-Oncologie voor Volwassenen Nederland
Het Ziekenhuisnetwerk Antwerpen, Antwerp
Registry updated 2020-12-10

All Hodgkin lymphoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error